These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients. Kuo HT; Lau C; Sampaio MS; Bunnapradist S Liver Transpl; 2010 Nov; 16(11):1249-56. PubMed ID: 21031540 [TBL] [Abstract][Full Text] [Related]
44. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A. Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients. Ye X; Kuo HT; Sampaio MS; Jiang Y; Bunnapradist S Clin Transplant; 2011; 25(6):885-91. PubMed ID: 21175848 [TBL] [Abstract][Full Text] [Related]
47. [Sugar diabetes after renal transplantation in children]. Robert JJ; Tete MJ; Crosnier H; Broyer M Ann Pediatr (Paris); 1993 Feb; 40(2):112-8. PubMed ID: 8457131 [TBL] [Abstract][Full Text] [Related]
48. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients. Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594 [TBL] [Abstract][Full Text] [Related]
49. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus. Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806 [TBL] [Abstract][Full Text] [Related]
55. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661 [TBL] [Abstract][Full Text] [Related]
56. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K; Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344 [TBL] [Abstract][Full Text] [Related]
57. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. Walker S; Habib S; Rose M; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618 [No Abstract] [Full Text] [Related]
58. Post-transplant diabetes mellitus. The role of immunosuppression. Jindal RM; Sidner RA; Milgrom ML Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492 [TBL] [Abstract][Full Text] [Related]
59. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study. Lorho R; Hardwigsen J; Dumortier J; Pageaux GP; Durand F; Bizollon T; Blanc AS; Di Giambattista F; Duvoux C Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):482-8. PubMed ID: 21530445 [TBL] [Abstract][Full Text] [Related]